Barinthus Biotherapeutics plc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
  • Barinthus Biotherapeutics plc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.14M, a 1907% increase year-over-year.
  • Barinthus Biotherapeutics plc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $4.74M, a 24.9% decline year-over-year.
  • Barinthus Biotherapeutics plc. annual Share-based Payment Arrangement, Expense for 2023 was $5.06M, a 48.8% decline from 2022.
  • Barinthus Biotherapeutics plc. annual Share-based Payment Arrangement, Expense for 2022 was $9.88M, a 40.1% decline from 2021.
  • Barinthus Biotherapeutics plc. annual Share-based Payment Arrangement, Expense for 2021 was $16.5M, a 355% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.74M $1.14M +$1.09M +1907% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $3.65M $1.2M -$795K -40% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.45M $1.62M -$607K -27.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $5.06M $786K -$1.26M -61.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $6.31M $57K -$1.05M -94.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $7.36M $1.99M -$758K -27.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $8.12M $2.22M -$1.76M -44.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $9.88M $2.04M -$1.54M -43% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $11.4M $1.1M -$2.27M -67.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $13.7M $2.75M -$5.99M -68.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $19.7M $3.98M +$3.19M +400% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $16.5M $3.58M +$1.38M +62.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $15.1M $3.37M +$3.22M +2091% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $11.9M $8.74M +$8.32M +2005% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $3.57M $797K -$59K -6.89% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $3.63M $2.2M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 $154K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $415K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $856K Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.